Global Veterinary Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Veterinary Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Veterinary Vaccine market.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Global veterinary vaccine key players include Merck, Zoetis, Boehringer Ingelheim, Ceva, and others. The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%. Global origins are mainly in North America, Europe, China, India, Latin America, South America, South Korea, Japan, Turkey, Middle East, Southeast Asia, etc. In terms of their products, live attenuated vaccines have the largest market share with a 50% share, followed by inactivated vaccines. In terms of its application, farm animals are the number one target, with a 70% market share.
Key Features:
The report on Veterinary Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Veterinary Vaccine market. It may include historical data, market segmentation by Type (e.g., Live Attenuated Vaccines, Inactivated Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Veterinary Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Veterinary Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Veterinary Vaccine industry. This include advancements in Veterinary Vaccine technology, Veterinary Vaccine new entrants, Veterinary Vaccine new investment, and other innovations that are shaping the future of Veterinary Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Veterinary Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Veterinary Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Veterinary Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Veterinary Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Veterinary Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Veterinary Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Veterinary Vaccine market.
Market Segmentation:
Veterinary Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Veterinary Vaccine market?
What factors are driving Veterinary Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Vaccine market opportunities vary by end market size?
How does Veterinary Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Veterinary Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Veterinary Vaccine market.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Global veterinary vaccine key players include Merck, Zoetis, Boehringer Ingelheim, Ceva, and others. The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%. Global origins are mainly in North America, Europe, China, India, Latin America, South America, South Korea, Japan, Turkey, Middle East, Southeast Asia, etc. In terms of their products, live attenuated vaccines have the largest market share with a 50% share, followed by inactivated vaccines. In terms of its application, farm animals are the number one target, with a 70% market share.
Key Features:
The report on Veterinary Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Veterinary Vaccine market. It may include historical data, market segmentation by Type (e.g., Live Attenuated Vaccines, Inactivated Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Veterinary Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Veterinary Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Veterinary Vaccine industry. This include advancements in Veterinary Vaccine technology, Veterinary Vaccine new entrants, Veterinary Vaccine new investment, and other innovations that are shaping the future of Veterinary Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Veterinary Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Veterinary Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Veterinary Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Veterinary Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Veterinary Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Veterinary Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Veterinary Vaccine market.
Market Segmentation:
Veterinary Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Live Attenuated Vaccines
- Inactivated Vaccines
- Other
- Farm Animal
- Companion Animal
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- RVSRI
- Medion
What is the 10-year outlook for the global Veterinary Vaccine market?
What factors are driving Veterinary Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Vaccine market opportunities vary by end market size?
How does Veterinary Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Veterinary Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Veterinary Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Veterinary Vaccine Segment by Type
2.2.1 Live Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.2.3 Other
2.3 Veterinary Vaccine Sales by Type
2.3.1 Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Veterinary Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Veterinary Vaccine Sale Price by Type (2019-2024)
2.4 Veterinary Vaccine Segment by Application
2.4.1 Farm Animal
2.4.2 Companion Animal
2.5 Veterinary Vaccine Sales by Application
2.5.1 Global Veterinary Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Veterinary Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Veterinary Vaccine Sale Price by Application (2019-2024)
3 GLOBAL VETERINARY VACCINE BY COMPANY
3.1 Global Veterinary Vaccine Breakdown Data by Company
3.1.1 Global Veterinary Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Veterinary Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Veterinary Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Veterinary Vaccine Revenue by Company (2019-2024)
3.2.2 Global Veterinary Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Veterinary Vaccine Sale Price by Company
3.4 Key Manufacturers Veterinary Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Vaccine Product Location Distribution
3.4.2 Players Veterinary Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VETERINARY VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Veterinary Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Veterinary Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Veterinary Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Veterinary Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Veterinary Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Veterinary Vaccine Sales Growth
4.4 APAC Veterinary Vaccine Sales Growth
4.5 Europe Veterinary Vaccine Sales Growth
4.6 Middle East & Africa Veterinary Vaccine Sales Growth
5 AMERICAS
5.1 Americas Veterinary Vaccine Sales by Country
5.1.1 Americas Veterinary Vaccine Sales by Country (2019-2024)
5.1.2 Americas Veterinary Vaccine Revenue by Country (2019-2024)
5.2 Americas Veterinary Vaccine Sales by Type
5.3 Americas Veterinary Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Vaccine Sales by Region
6.1.1 APAC Veterinary Vaccine Sales by Region (2019-2024)
6.1.2 APAC Veterinary Vaccine Revenue by Region (2019-2024)
6.2 APAC Veterinary Vaccine Sales by Type
6.3 APAC Veterinary Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Vaccine by Country
7.1.1 Europe Veterinary Vaccine Sales by Country (2019-2024)
7.1.2 Europe Veterinary Vaccine Revenue by Country (2019-2024)
7.2 Europe Veterinary Vaccine Sales by Type
7.3 Europe Veterinary Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Vaccine by Country
8.1.1 Middle East & Africa Veterinary Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Veterinary Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Veterinary Vaccine Sales by Type
8.3 Middle East & Africa Veterinary Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Vaccine
10.3 Manufacturing Process Analysis of Veterinary Vaccine
10.4 Industry Chain Structure of Veterinary Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Vaccine Distributors
11.3 Veterinary Vaccine Customer
12 WORLD FORECAST REVIEW FOR VETERINARY VACCINE BY GEOGRAPHIC REGION
12.1 Global Veterinary Vaccine Market Size Forecast by Region
12.1.1 Global Veterinary Vaccine Forecast by Region (2025-2030)
12.1.2 Global Veterinary Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Vaccine Forecast by Type
12.7 Global Veterinary Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Vaccine Product Portfolios and Specifications
13.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Vaccine Product Portfolios and Specifications
13.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Vaccine Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Vaccine Product Portfolios and Specifications
13.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Ringpu Biology
13.7.1 Ringpu Biology Company Information
13.7.2 Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
13.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ringpu Biology Main Business Overview
13.7.5 Ringpu Biology Latest Developments
13.8 Yebio
13.8.1 Yebio Company Information
13.8.2 Yebio Veterinary Vaccine Product Portfolios and Specifications
13.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Yebio Main Business Overview
13.8.5 Yebio Latest Developments
13.9 DHN
13.9.1 DHN Company Information
13.9.2 DHN Veterinary Vaccine Product Portfolios and Specifications
13.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 DHN Main Business Overview
13.9.5 DHN Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Veterinary Vaccine Product Portfolios and Specifications
13.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Elanco
13.11.1 Elanco Company Information
13.11.2 Elanco Veterinary Vaccine Product Portfolios and Specifications
13.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Elanco Main Business Overview
13.11.5 Elanco Latest Developments
13.12 Virbac
13.12.1 Virbac Company Information
13.12.2 Virbac Veterinary Vaccine Product Portfolios and Specifications
13.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Virbac Main Business Overview
13.12.5 Virbac Latest Developments
13.13 Jinyu Bio-Technology
13.13.1 Jinyu Bio-Technology Company Information
13.13.2 Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Jinyu Bio-Technology Main Business Overview
13.13.5 Jinyu Bio-Technology Latest Developments
13.14 ChengDu Tecbond
13.14.1 ChengDu Tecbond Company Information
13.14.2 ChengDu Tecbond Veterinary Vaccine Product Portfolios and Specifications
13.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 ChengDu Tecbond Main Business Overview
13.14.5 ChengDu Tecbond Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Veterinary Vaccine Product Portfolios and Specifications
13.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Kyoto Biken Laboratories
13.16.1 Kyoto Biken Laboratories Company Information
13.16.2 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
13.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Kyoto Biken Laboratories Main Business Overview
13.16.5 Kyoto Biken Laboratories Latest Developments
13.17 FATRO
13.17.1 FATRO Company Information
13.17.2 FATRO Veterinary Vaccine Product Portfolios and Specifications
13.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 FATRO Main Business Overview
13.17.5 FATRO Latest Developments
13.18 Vaksindo
13.18.1 Vaksindo Company Information
13.18.2 Vaksindo Veterinary Vaccine Product Portfolios and Specifications
13.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Vaksindo Main Business Overview
13.18.5 Vaksindo Latest Developments
13.19 Bio-Labs
13.19.1 Bio-Labs Company Information
13.19.2 Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
13.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Bio-Labs Main Business Overview
13.19.5 Bio-Labs Latest Developments
13.20 Avimex Animal Health
13.20.1 Avimex Animal Health Company Information
13.20.2 Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
13.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Avimex Animal Health Main Business Overview
13.20.5 Avimex Animal Health Latest Developments
13.21 MEVAC
13.21.1 MEVAC Company Information
13.21.2 MEVAC Veterinary Vaccine Product Portfolios and Specifications
13.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 MEVAC Main Business Overview
13.21.5 MEVAC Latest Developments
13.22 Biovac
13.22.1 Biovac Company Information
13.22.2 Biovac Veterinary Vaccine Product Portfolios and Specifications
13.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Biovac Main Business Overview
13.22.5 Biovac Latest Developments
13.23 Atafen
13.23.1 Atafen Company Information
13.23.2 Atafen Veterinary Vaccine Product Portfolios and Specifications
13.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Atafen Main Business Overview
13.23.5 Atafen Latest Developments
13.24 Dyntec
13.24.1 Dyntec Company Information
13.24.2 Dyntec Veterinary Vaccine Product Portfolios and Specifications
13.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Dyntec Main Business Overview
13.24.5 Dyntec Latest Developments
13.25 RVSRI
13.25.1 RVSRI Company Information
13.25.2 RVSRI Veterinary Vaccine Product Portfolios and Specifications
13.25.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 RVSRI Main Business Overview
13.25.5 RVSRI Latest Developments
13.26 Medion
13.26.1 Medion Company Information
13.26.2 Medion Veterinary Vaccine Product Portfolios and Specifications
13.26.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Medion Main Business Overview
13.26.5 Medion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Veterinary Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Veterinary Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Veterinary Vaccine Segment by Type
2.2.1 Live Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.2.3 Other
2.3 Veterinary Vaccine Sales by Type
2.3.1 Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Veterinary Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Veterinary Vaccine Sale Price by Type (2019-2024)
2.4 Veterinary Vaccine Segment by Application
2.4.1 Farm Animal
2.4.2 Companion Animal
2.5 Veterinary Vaccine Sales by Application
2.5.1 Global Veterinary Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Veterinary Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Veterinary Vaccine Sale Price by Application (2019-2024)
3 GLOBAL VETERINARY VACCINE BY COMPANY
3.1 Global Veterinary Vaccine Breakdown Data by Company
3.1.1 Global Veterinary Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Veterinary Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Veterinary Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Veterinary Vaccine Revenue by Company (2019-2024)
3.2.2 Global Veterinary Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Veterinary Vaccine Sale Price by Company
3.4 Key Manufacturers Veterinary Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Vaccine Product Location Distribution
3.4.2 Players Veterinary Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VETERINARY VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Veterinary Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Veterinary Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Veterinary Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Veterinary Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Veterinary Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Veterinary Vaccine Sales Growth
4.4 APAC Veterinary Vaccine Sales Growth
4.5 Europe Veterinary Vaccine Sales Growth
4.6 Middle East & Africa Veterinary Vaccine Sales Growth
5 AMERICAS
5.1 Americas Veterinary Vaccine Sales by Country
5.1.1 Americas Veterinary Vaccine Sales by Country (2019-2024)
5.1.2 Americas Veterinary Vaccine Revenue by Country (2019-2024)
5.2 Americas Veterinary Vaccine Sales by Type
5.3 Americas Veterinary Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Vaccine Sales by Region
6.1.1 APAC Veterinary Vaccine Sales by Region (2019-2024)
6.1.2 APAC Veterinary Vaccine Revenue by Region (2019-2024)
6.2 APAC Veterinary Vaccine Sales by Type
6.3 APAC Veterinary Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Vaccine by Country
7.1.1 Europe Veterinary Vaccine Sales by Country (2019-2024)
7.1.2 Europe Veterinary Vaccine Revenue by Country (2019-2024)
7.2 Europe Veterinary Vaccine Sales by Type
7.3 Europe Veterinary Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Vaccine by Country
8.1.1 Middle East & Africa Veterinary Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Veterinary Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Veterinary Vaccine Sales by Type
8.3 Middle East & Africa Veterinary Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Vaccine
10.3 Manufacturing Process Analysis of Veterinary Vaccine
10.4 Industry Chain Structure of Veterinary Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Vaccine Distributors
11.3 Veterinary Vaccine Customer
12 WORLD FORECAST REVIEW FOR VETERINARY VACCINE BY GEOGRAPHIC REGION
12.1 Global Veterinary Vaccine Market Size Forecast by Region
12.1.1 Global Veterinary Vaccine Forecast by Region (2025-2030)
12.1.2 Global Veterinary Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Vaccine Forecast by Type
12.7 Global Veterinary Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Vaccine Product Portfolios and Specifications
13.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Veterinary Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Veterinary Vaccine Product Portfolios and Specifications
13.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 CAHIC
13.5.1 CAHIC Company Information
13.5.2 CAHIC Veterinary Vaccine Product Portfolios and Specifications
13.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CAHIC Main Business Overview
13.5.5 CAHIC Latest Developments
13.6 HVRI
13.6.1 HVRI Company Information
13.6.2 HVRI Veterinary Vaccine Product Portfolios and Specifications
13.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 HVRI Main Business Overview
13.6.5 HVRI Latest Developments
13.7 Ringpu Biology
13.7.1 Ringpu Biology Company Information
13.7.2 Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
13.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ringpu Biology Main Business Overview
13.7.5 Ringpu Biology Latest Developments
13.8 Yebio
13.8.1 Yebio Company Information
13.8.2 Yebio Veterinary Vaccine Product Portfolios and Specifications
13.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Yebio Main Business Overview
13.8.5 Yebio Latest Developments
13.9 DHN
13.9.1 DHN Company Information
13.9.2 DHN Veterinary Vaccine Product Portfolios and Specifications
13.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 DHN Main Business Overview
13.9.5 DHN Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Veterinary Vaccine Product Portfolios and Specifications
13.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Elanco
13.11.1 Elanco Company Information
13.11.2 Elanco Veterinary Vaccine Product Portfolios and Specifications
13.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Elanco Main Business Overview
13.11.5 Elanco Latest Developments
13.12 Virbac
13.12.1 Virbac Company Information
13.12.2 Virbac Veterinary Vaccine Product Portfolios and Specifications
13.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Virbac Main Business Overview
13.12.5 Virbac Latest Developments
13.13 Jinyu Bio-Technology
13.13.1 Jinyu Bio-Technology Company Information
13.13.2 Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Jinyu Bio-Technology Main Business Overview
13.13.5 Jinyu Bio-Technology Latest Developments
13.14 ChengDu Tecbond
13.14.1 ChengDu Tecbond Company Information
13.14.2 ChengDu Tecbond Veterinary Vaccine Product Portfolios and Specifications
13.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 ChengDu Tecbond Main Business Overview
13.14.5 ChengDu Tecbond Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Veterinary Vaccine Product Portfolios and Specifications
13.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Kyoto Biken Laboratories
13.16.1 Kyoto Biken Laboratories Company Information
13.16.2 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
13.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Kyoto Biken Laboratories Main Business Overview
13.16.5 Kyoto Biken Laboratories Latest Developments
13.17 FATRO
13.17.1 FATRO Company Information
13.17.2 FATRO Veterinary Vaccine Product Portfolios and Specifications
13.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 FATRO Main Business Overview
13.17.5 FATRO Latest Developments
13.18 Vaksindo
13.18.1 Vaksindo Company Information
13.18.2 Vaksindo Veterinary Vaccine Product Portfolios and Specifications
13.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Vaksindo Main Business Overview
13.18.5 Vaksindo Latest Developments
13.19 Bio-Labs
13.19.1 Bio-Labs Company Information
13.19.2 Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
13.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Bio-Labs Main Business Overview
13.19.5 Bio-Labs Latest Developments
13.20 Avimex Animal Health
13.20.1 Avimex Animal Health Company Information
13.20.2 Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
13.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Avimex Animal Health Main Business Overview
13.20.5 Avimex Animal Health Latest Developments
13.21 MEVAC
13.21.1 MEVAC Company Information
13.21.2 MEVAC Veterinary Vaccine Product Portfolios and Specifications
13.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 MEVAC Main Business Overview
13.21.5 MEVAC Latest Developments
13.22 Biovac
13.22.1 Biovac Company Information
13.22.2 Biovac Veterinary Vaccine Product Portfolios and Specifications
13.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Biovac Main Business Overview
13.22.5 Biovac Latest Developments
13.23 Atafen
13.23.1 Atafen Company Information
13.23.2 Atafen Veterinary Vaccine Product Portfolios and Specifications
13.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Atafen Main Business Overview
13.23.5 Atafen Latest Developments
13.24 Dyntec
13.24.1 Dyntec Company Information
13.24.2 Dyntec Veterinary Vaccine Product Portfolios and Specifications
13.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Dyntec Main Business Overview
13.24.5 Dyntec Latest Developments
13.25 RVSRI
13.25.1 RVSRI Company Information
13.25.2 RVSRI Veterinary Vaccine Product Portfolios and Specifications
13.25.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 RVSRI Main Business Overview
13.25.5 RVSRI Latest Developments
13.26 Medion
13.26.1 Medion Company Information
13.26.2 Medion Veterinary Vaccine Product Portfolios and Specifications
13.26.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Medion Main Business Overview
13.26.5 Medion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Veterinary Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Veterinary Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Major Players of Other
Table 6. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 7. Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global Veterinary Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global Veterinary Vaccine Sale Price by Type (2019-2024) & (USD/K Doses)
Table 11. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 12. Global Veterinary Vaccine Sales Market Share by Application (2019-2024)
Table 13. Global Veterinary Vaccine Revenue by Application (2019-2024)
Table 14. Global Veterinary Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global Veterinary Vaccine Sale Price by Application (2019-2024) & (USD/K Doses)
Table 16. Global Veterinary Vaccine Sales by Company (2019-2024) & (M Doses)
Table 17. Global Veterinary Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global Veterinary Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Veterinary Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global Veterinary Vaccine Sale Price by Company (2019-2024) & (USD/K Doses)
Table 21. Key Manufacturers Veterinary Vaccine Producing Area Distribution and Sales Area
Table 22. Players Veterinary Vaccine Products Offered
Table 23. Veterinary Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Veterinary Vaccine Sales by Geographic Region (2019-2024) & (M Doses)
Table 27. Global Veterinary Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Veterinary Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Veterinary Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Veterinary Vaccine Sales by Country/Region (2019-2024) & (M Doses)
Table 31. Global Veterinary Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Veterinary Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Veterinary Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 35. Americas Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas Veterinary Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Veterinary Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 39. Americas Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 40. APAC Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 41. APAC Veterinary Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC Veterinary Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Veterinary Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 45. APAC Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 46. Europe Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 47. Europe Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe Veterinary Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Veterinary Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 51. Europe Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Middle East & Africa Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 53. Middle East & Africa Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Veterinary Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 57. Middle East & Africa Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 58. Key Market Drivers & Growth Opportunities of Veterinary Vaccine
Table 59. Key Market Challenges & Risks of Veterinary Vaccine
Table 60. Key Industry Trends of Veterinary Vaccine
Table 61. Veterinary Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Veterinary Vaccine Distributors List
Table 64. Veterinary Vaccine Customer List
Table 65. Global Veterinary Vaccine Sales Forecast by Region (2025-2030) & (M Doses)
Table 66. Global Veterinary Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 68. Americas Veterinary Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Veterinary Vaccine Sales Forecast by Region (2025-2030) & (M Doses)
Table 70. APAC Veterinary Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 72. Europe Veterinary Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 74. Middle East & Africa Veterinary Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Veterinary Vaccine Sales Forecast by Type (2025-2030) & (M Doses)
Table 76. Global Veterinary Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Veterinary Vaccine Sales Forecast by Application (2025-2030) & (M Doses)
Table 78. Global Veterinary Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Merck Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Veterinary Vaccine Product Portfolios and Specifications
Table 81. Merck Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Zoetis Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Zoetis Veterinary Vaccine Product Portfolios and Specifications
Table 86. Zoetis Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 87. Zoetis Main Business
Table 88. Zoetis Latest Developments
Table 89. Boehringer Ingelheim Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
Table 91. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 92. Boehringer Ingelheim Main Business
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Ceva Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Ceva Veterinary Vaccine Product Portfolios and Specifications
Table 96. Ceva Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 97. Ceva Main Business
Table 98. Ceva Latest Developments
Table 99. CAHIC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CAHIC Veterinary Vaccine Product Portfolios and Specifications
Table 101. CAHIC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 102. CAHIC Main Business
Table 103. CAHIC Latest Developments
Table 104. HVRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. HVRI Veterinary Vaccine Product Portfolios and Specifications
Table 106. HVRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 107. HVRI Main Business
Table 108. HVRI Latest Developments
Table 109. Ringpu Biology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
Table 111. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 112. Ringpu Biology Main Business
Table 113. Ringpu Biology Latest Developments
Table 114. Yebio Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Yebio Veterinary Vaccine Product Portfolios and Specifications
Table 116. Yebio Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 117. Yebio Main Business
Table 118. Yebio Latest Developments
Table 119. DHN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. DHN Veterinary Vaccine Product Portfolios and Specifications
Table 121. DHN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 122. DHN Main Business
Table 123. DHN Latest Developments
Table 124. WINSUN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. WINSUN Veterinary Vaccine Product Portfolios and Specifications
Table 126. WINSUN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 127. WINSUN Main Business
Table 128. WINSUN Latest Developments
Table 129. Elanco Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Elanco Veterinary Vaccine Product Portfolios and Specifications
Table 131. Elanco Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 132. Elanco Main Business
Table 133. Elanco Latest Developments
Table 134. Virbac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Virbac Veterinary Vaccine Product Portfolios and Specifications
Table 136. Virbac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 137. Virbac Main Business
Table 138. Virbac Latest Developments
Table 139. Jinyu Bio-Technology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
Table 141. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 142. Jinyu Bio-Technology Main Business
Table 143. Jinyu Bio-Technology Latest Developments
Table 144. ChengDu Tecbond Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145. ChengDu Tecbond Veterinary Vaccine Product Portfolios and Specifications
Table 146. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 147. ChengDu Tecbond Main Business
Table 148. ChengDu Tecbond Latest Developments
Table 149. CAVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. CAVAC Veterinary Vaccine Product Portfolios and Specifications
Table 151. CAVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 152. CAVAC Main Business
Table 153. CAVAC Latest Developments
Table 154. Kyoto Biken Laboratories Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
Table 156. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 157. Kyoto Biken Laboratories Main Business
Table 158. Kyoto Biken Laboratories Latest Developments
Table 159. FATRO Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 160. FATRO Veterinary Vaccine Product Portfolios and Specifications
Table 161. FATRO Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 162. FATRO Main Business
Table 163. FATRO Latest Developments
Table 164. Vaksindo Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 165. Vaksindo Veterinary Vaccine Product Portfolios and Specifications
Table 166. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 167. Vaksindo Main Business
Table 168. Vaksindo Latest Developments
Table 169. Bio-Labs Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 170. Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
Table 171. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 172. Bio-Labs Main Business
Table 173. Bio-Labs Latest Developments
Table 174. Avimex Animal Health Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 175. Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
Table 176. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 177. Avimex Animal Health Main Business
Table 178. Avimex Animal Health Latest Developments
Table 179. MEVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 180. MEVAC Veterinary Vaccine Product Portfolios and Specifications
Table 181. MEVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 182. MEVAC Main Business
Table 183. MEVAC Latest Developments
Table 184. Biovac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 185. Biovac Veterinary Vaccine Product Portfolios and Specifications
Table 186. Biovac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 187. Biovac Main Business
Table 188. Biovac Latest Developments
Table 189. Atafen Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 190. Atafen Veterinary Vaccine Product Portfolios and Specifications
Table 191. Atafen Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 192. Atafen Main Business
Table 193. Atafen Latest Developments
Table 194. Dyntec Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 195. Dyntec Veterinary Vaccine Product Portfolios and Specifications
Table 196. Dyntec Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 197. Dyntec Main Business
Table 198. Dyntec Latest Developments
Table 199. RVSRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 200. RVSRI Veterinary Vaccine Product Portfolios and Specifications
Table 201. RVSRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 202. RVSRI Main Business
Table 203. RVSRI Latest Developments
Table 204. Medion Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 205. Medion Veterinary Vaccine Product Portfolios and Specifications
Table 206. Medion Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 207. Medion Main Business
Table 208. Medion Latest Developments
Table 1. Veterinary Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Veterinary Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Major Players of Other
Table 6. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 7. Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global Veterinary Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global Veterinary Vaccine Sale Price by Type (2019-2024) & (USD/K Doses)
Table 11. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 12. Global Veterinary Vaccine Sales Market Share by Application (2019-2024)
Table 13. Global Veterinary Vaccine Revenue by Application (2019-2024)
Table 14. Global Veterinary Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global Veterinary Vaccine Sale Price by Application (2019-2024) & (USD/K Doses)
Table 16. Global Veterinary Vaccine Sales by Company (2019-2024) & (M Doses)
Table 17. Global Veterinary Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global Veterinary Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Veterinary Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global Veterinary Vaccine Sale Price by Company (2019-2024) & (USD/K Doses)
Table 21. Key Manufacturers Veterinary Vaccine Producing Area Distribution and Sales Area
Table 22. Players Veterinary Vaccine Products Offered
Table 23. Veterinary Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Veterinary Vaccine Sales by Geographic Region (2019-2024) & (M Doses)
Table 27. Global Veterinary Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Veterinary Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Veterinary Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Veterinary Vaccine Sales by Country/Region (2019-2024) & (M Doses)
Table 31. Global Veterinary Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Veterinary Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Veterinary Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 35. Americas Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas Veterinary Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Veterinary Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 39. Americas Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 40. APAC Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 41. APAC Veterinary Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC Veterinary Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Veterinary Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 45. APAC Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 46. Europe Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 47. Europe Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe Veterinary Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Veterinary Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 51. Europe Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Middle East & Africa Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 53. Middle East & Africa Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Veterinary Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 57. Middle East & Africa Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 58. Key Market Drivers & Growth Opportunities of Veterinary Vaccine
Table 59. Key Market Challenges & Risks of Veterinary Vaccine
Table 60. Key Industry Trends of Veterinary Vaccine
Table 61. Veterinary Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Veterinary Vaccine Distributors List
Table 64. Veterinary Vaccine Customer List
Table 65. Global Veterinary Vaccine Sales Forecast by Region (2025-2030) & (M Doses)
Table 66. Global Veterinary Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 68. Americas Veterinary Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Veterinary Vaccine Sales Forecast by Region (2025-2030) & (M Doses)
Table 70. APAC Veterinary Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 72. Europe Veterinary Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 74. Middle East & Africa Veterinary Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Veterinary Vaccine Sales Forecast by Type (2025-2030) & (M Doses)
Table 76. Global Veterinary Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Veterinary Vaccine Sales Forecast by Application (2025-2030) & (M Doses)
Table 78. Global Veterinary Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Merck Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Veterinary Vaccine Product Portfolios and Specifications
Table 81. Merck Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Zoetis Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Zoetis Veterinary Vaccine Product Portfolios and Specifications
Table 86. Zoetis Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 87. Zoetis Main Business
Table 88. Zoetis Latest Developments
Table 89. Boehringer Ingelheim Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Ingelheim Veterinary Vaccine Product Portfolios and Specifications
Table 91. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 92. Boehringer Ingelheim Main Business
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Ceva Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Ceva Veterinary Vaccine Product Portfolios and Specifications
Table 96. Ceva Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 97. Ceva Main Business
Table 98. Ceva Latest Developments
Table 99. CAHIC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CAHIC Veterinary Vaccine Product Portfolios and Specifications
Table 101. CAHIC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 102. CAHIC Main Business
Table 103. CAHIC Latest Developments
Table 104. HVRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. HVRI Veterinary Vaccine Product Portfolios and Specifications
Table 106. HVRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 107. HVRI Main Business
Table 108. HVRI Latest Developments
Table 109. Ringpu Biology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Ringpu Biology Veterinary Vaccine Product Portfolios and Specifications
Table 111. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 112. Ringpu Biology Main Business
Table 113. Ringpu Biology Latest Developments
Table 114. Yebio Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Yebio Veterinary Vaccine Product Portfolios and Specifications
Table 116. Yebio Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 117. Yebio Main Business
Table 118. Yebio Latest Developments
Table 119. DHN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. DHN Veterinary Vaccine Product Portfolios and Specifications
Table 121. DHN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 122. DHN Main Business
Table 123. DHN Latest Developments
Table 124. WINSUN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. WINSUN Veterinary Vaccine Product Portfolios and Specifications
Table 126. WINSUN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 127. WINSUN Main Business
Table 128. WINSUN Latest Developments
Table 129. Elanco Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Elanco Veterinary Vaccine Product Portfolios and Specifications
Table 131. Elanco Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 132. Elanco Main Business
Table 133. Elanco Latest Developments
Table 134. Virbac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Virbac Veterinary Vaccine Product Portfolios and Specifications
Table 136. Virbac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 137. Virbac Main Business
Table 138. Virbac Latest Developments
Table 139. Jinyu Bio-Technology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Jinyu Bio-Technology Veterinary Vaccine Product Portfolios and Specifications
Table 141. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 142. Jinyu Bio-Technology Main Business
Table 143. Jinyu Bio-Technology Latest Developments
Table 144. ChengDu Tecbond Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145. ChengDu Tecbond Veterinary Vaccine Product Portfolios and Specifications
Table 146. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 147. ChengDu Tecbond Main Business
Table 148. ChengDu Tecbond Latest Developments
Table 149. CAVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. CAVAC Veterinary Vaccine Product Portfolios and Specifications
Table 151. CAVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 152. CAVAC Main Business
Table 153. CAVAC Latest Developments
Table 154. Kyoto Biken Laboratories Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolios and Specifications
Table 156. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 157. Kyoto Biken Laboratories Main Business
Table 158. Kyoto Biken Laboratories Latest Developments
Table 159. FATRO Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 160. FATRO Veterinary Vaccine Product Portfolios and Specifications
Table 161. FATRO Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 162. FATRO Main Business
Table 163. FATRO Latest Developments
Table 164. Vaksindo Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 165. Vaksindo Veterinary Vaccine Product Portfolios and Specifications
Table 166. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 167. Vaksindo Main Business
Table 168. Vaksindo Latest Developments
Table 169. Bio-Labs Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 170. Bio-Labs Veterinary Vaccine Product Portfolios and Specifications
Table 171. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 172. Bio-Labs Main Business
Table 173. Bio-Labs Latest Developments
Table 174. Avimex Animal Health Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 175. Avimex Animal Health Veterinary Vaccine Product Portfolios and Specifications
Table 176. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 177. Avimex Animal Health Main Business
Table 178. Avimex Animal Health Latest Developments
Table 179. MEVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 180. MEVAC Veterinary Vaccine Product Portfolios and Specifications
Table 181. MEVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 182. MEVAC Main Business
Table 183. MEVAC Latest Developments
Table 184. Biovac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 185. Biovac Veterinary Vaccine Product Portfolios and Specifications
Table 186. Biovac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 187. Biovac Main Business
Table 188. Biovac Latest Developments
Table 189. Atafen Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 190. Atafen Veterinary Vaccine Product Portfolios and Specifications
Table 191. Atafen Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 192. Atafen Main Business
Table 193. Atafen Latest Developments
Table 194. Dyntec Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 195. Dyntec Veterinary Vaccine Product Portfolios and Specifications
Table 196. Dyntec Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 197. Dyntec Main Business
Table 198. Dyntec Latest Developments
Table 199. RVSRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 200. RVSRI Veterinary Vaccine Product Portfolios and Specifications
Table 201. RVSRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 202. RVSRI Main Business
Table 203. RVSRI Latest Developments
Table 204. Medion Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 205. Medion Veterinary Vaccine Product Portfolios and Specifications
Table 206. Medion Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 207. Medion Main Business
Table 208. Medion Latest Developments
LIST OF FIGURES
Figure 1. Picture of Veterinary Vaccine
Figure 2. Veterinary Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Vaccine Sales Growth Rate 2019-2030 (M Doses)
Figure 7. Global Veterinary Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Veterinary Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Live Attenuated Vaccines
Figure 10. Product Picture of Inactivated Vaccines
Figure 11. Product Picture of Other
Figure 12. Global Veterinary Vaccine Sales Market Share by Type in 2023
Figure 13. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. Veterinary Vaccine Consumed in Farm Animal
Figure 15. Global Veterinary Vaccine Market: Farm Animal (2019-2024) & (M Doses)
Figure 16. Veterinary Vaccine Consumed in Companion Animal
Figure 17. Global Veterinary Vaccine Market: Companion Animal (2019-2024) & (M Doses)
Figure 18. Global Veterinary Vaccine Sales Market Share by Application (2023)
Figure 19. Global Veterinary Vaccine Revenue Market Share by Application in 2023
Figure 20. Veterinary Vaccine Sales Market by Company in 2023 (M Doses)
Figure 21. Global Veterinary Vaccine Sales Market Share by Company in 2023
Figure 22. Veterinary Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Veterinary Vaccine Revenue Market Share by Company in 2023
Figure 24. Global Veterinary Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Veterinary Vaccine Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Veterinary Vaccine Sales 2019-2024 (M Doses)
Figure 27. Americas Veterinary Vaccine Revenue 2019-2024 ($ Millions)
Figure 28. APAC Veterinary Vaccine Sales 2019-2024 (M Doses)
Figure 29. APAC Veterinary Vaccine Revenue 2019-2024 ($ Millions)
Figure 30. Europe Veterinary Vaccine Sales 2019-2024 (M Doses)
Figure 31. Europe Veterinary Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Veterinary Vaccine Sales 2019-2024 (M Doses)
Figure 33. Middle East & Africa Veterinary Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Americas Veterinary Vaccine Sales Market Share by Country in 2023
Figure 35. Americas Veterinary Vaccine Revenue Market Share by Country in 2023
Figure 36. Americas Veterinary Vaccine Sales Market Share by Type (2019-2024)
Figure 37. Americas Veterinary Vaccine Sales Market Share by Application (2019-2024)
Figure 38. United States Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Veterinary Vaccine Sales Market Share by Region in 2023
Figure 43. APAC Veterinary Vaccine Revenue Market Share by Regions in 2023
Figure 44. APAC Veterinary Vaccine Sales Market Share by Type (2019-2024)
Figure 45. APAC Veterinary Vaccine Sales Market Share by Application (2019-2024)
Figure 46. China Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Veterinary Vaccine Sales Market Share by Country in 2023
Figure 54. Europe Veterinary Vaccine Revenue Market Share by Country in 2023
Figure 55. Europe Veterinary Vaccine Sales Market Share by Type (2019-2024)
Figure 56. Europe Veterinary Vaccine Sales Market Share by Application (2019-2024)
Figure 57. Germany Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Veterinary Vaccine Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Veterinary Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Veterinary Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Veterinary Vaccine in 2023
Figure 72. Manufacturing Process Analysis of Veterinary Vaccine
Figure 73. Industry Chain Structure of Veterinary Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Veterinary Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global Veterinary Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Veterinary Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Veterinary Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Veterinary Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Veterinary Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Veterinary Vaccine
Figure 2. Veterinary Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Vaccine Sales Growth Rate 2019-2030 (M Doses)
Figure 7. Global Veterinary Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Veterinary Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Live Attenuated Vaccines
Figure 10. Product Picture of Inactivated Vaccines
Figure 11. Product Picture of Other
Figure 12. Global Veterinary Vaccine Sales Market Share by Type in 2023
Figure 13. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. Veterinary Vaccine Consumed in Farm Animal
Figure 15. Global Veterinary Vaccine Market: Farm Animal (2019-2024) & (M Doses)
Figure 16. Veterinary Vaccine Consumed in Companion Animal
Figure 17. Global Veterinary Vaccine Market: Companion Animal (2019-2024) & (M Doses)
Figure 18. Global Veterinary Vaccine Sales Market Share by Application (2023)
Figure 19. Global Veterinary Vaccine Revenue Market Share by Application in 2023
Figure 20. Veterinary Vaccine Sales Market by Company in 2023 (M Doses)
Figure 21. Global Veterinary Vaccine Sales Market Share by Company in 2023
Figure 22. Veterinary Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Veterinary Vaccine Revenue Market Share by Company in 2023
Figure 24. Global Veterinary Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Veterinary Vaccine Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Veterinary Vaccine Sales 2019-2024 (M Doses)
Figure 27. Americas Veterinary Vaccine Revenue 2019-2024 ($ Millions)
Figure 28. APAC Veterinary Vaccine Sales 2019-2024 (M Doses)
Figure 29. APAC Veterinary Vaccine Revenue 2019-2024 ($ Millions)
Figure 30. Europe Veterinary Vaccine Sales 2019-2024 (M Doses)
Figure 31. Europe Veterinary Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Veterinary Vaccine Sales 2019-2024 (M Doses)
Figure 33. Middle East & Africa Veterinary Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Americas Veterinary Vaccine Sales Market Share by Country in 2023
Figure 35. Americas Veterinary Vaccine Revenue Market Share by Country in 2023
Figure 36. Americas Veterinary Vaccine Sales Market Share by Type (2019-2024)
Figure 37. Americas Veterinary Vaccine Sales Market Share by Application (2019-2024)
Figure 38. United States Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Veterinary Vaccine Sales Market Share by Region in 2023
Figure 43. APAC Veterinary Vaccine Revenue Market Share by Regions in 2023
Figure 44. APAC Veterinary Vaccine Sales Market Share by Type (2019-2024)
Figure 45. APAC Veterinary Vaccine Sales Market Share by Application (2019-2024)
Figure 46. China Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Veterinary Vaccine Sales Market Share by Country in 2023
Figure 54. Europe Veterinary Vaccine Revenue Market Share by Country in 2023
Figure 55. Europe Veterinary Vaccine Sales Market Share by Type (2019-2024)
Figure 56. Europe Veterinary Vaccine Sales Market Share by Application (2019-2024)
Figure 57. Germany Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Veterinary Vaccine Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Veterinary Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Veterinary Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Veterinary Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Veterinary Vaccine in 2023
Figure 72. Manufacturing Process Analysis of Veterinary Vaccine
Figure 73. Industry Chain Structure of Veterinary Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Veterinary Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global Veterinary Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Veterinary Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Veterinary Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Veterinary Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Veterinary Vaccine Revenue Market Share Forecast by Application (2025-2030)